0001231919-25-000162.txt : 20250825 0001231919-25-000162.hdr.sgml : 20250825 20250825151748 ACCESSION NUMBER: 0001231919-25-000162 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250825 DATE AS OF CHANGE: 20250825 EFFECTIVENESS DATE: 20250825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cascade Biocatalysts, Inc. CENTRAL INDEX KEY: 0002083126 ORGANIZATION NAME: EIN: 921222295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-555703 FILM NUMBER: 251250507 BUSINESS ADDRESS: STREET 1: 3960 NIAGARA STREET STREET 2: SUITE B CITY: DENVER STATE: CO ZIP: 80207 BUSINESS PHONE: (310) 913-0576 MAIL ADDRESS: STREET 1: 3960 NIAGARA STREET STREET 2: SUITE B CITY: DENVER STATE: CO ZIP: 80207 D 1 primary_doc.xml X0708 D LIVE 0002083126 Cascade Biocatalysts, Inc. 3960 NIAGARA STREET SUITE B DENVER CO COLORADO 80207 (310) 913-0576 DELAWARE None None Corporation true 2022 Alexander Rosay 3960 Niagara Street Suite B Denver CO COLORADO 80207 Executive Officer Director Promoter James Weltz 3960 Niagara Street Suite B Denver CO COLORADO 80207 Executive Officer Director Promoter Jared Campbell 3960 Niagara Street Suite B Denver CO COLORADO 80207 Director Biotechnology Decline to Disclose 06b false 2025-08-08 false true false 0 5616959 5441785 175174 false 41 0 0 0 false Cascade Biocatalysts, Inc. Alexander Rosay Alexander Rosay Chief Executive Officer 2025-08-25